MENLO PARK, CA, LevitasBio, an end-to-end sample processing and analysis provider to the life sciences market, announced it has completed Series C round financing.
LevitasBio, an end-to-end sample processing and analysis provider to the life sciences market, announced it has completed Series C round financing of $35 million to advance its mission of providing powerful, industry-leading methods of cellular analysis.
(c) by Massinvestor, Inc. For contact info, please check out our
about page.
